Grifols Sa Adr Stock Today

GIKLY Stock  USD 4.34  0.09  2.12%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Grifols SA is trading at 4.34 as of the 13th of February 2025; that is 2.12% increase since the beginning of the trading day. The stock's open price was 4.25. Grifols SA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 14th of January 2025 and ending today, the 13th of February 2025. Click here to learn more.
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.36 B outstanding shares. More on Grifols SA ADR

Moving against Grifols Pink Sheet

  0.66LLY Eli LillyPairCorr
  0.65RHHBY Roche HoldingPairCorr
  0.62RHHBF Roche Holding AGPairCorr
  0.62RHHVF Roche Holding AGPairCorr
  0.57AZN AstraZeneca PLC ADRPairCorr
  0.49AZNCF AstraZeneca PLCPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Grifols Pink Sheet Highlights

PresidentDavid Bell
Business ConcentrationDrug Manufacturers—General, Healthcare (View all Sectors)
Grifols SA ADR [GIKLY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 9.97 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Grifols SA's market, we take the total number of its shares issued and multiply it by Grifols SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Grifols SA ADR classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.36 B outstanding shares. Grifols SA ADR has accumulated about 549.09 M in cash with 596.98 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Check Grifols SA Probability Of Bankruptcy
Ownership Allocation
Grifols SA ADR has a total of 1.36 Billion outstanding shares. Roughly 99.98 (percent) of Grifols SA outstanding shares are held by general public with 0.02 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Public99.98%I...100%
Check Grifols Ownership Details

Grifols SA ADR Risk Profiles

Grifols Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Grifols SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module

Grifols SA Corporate Management

Nuria LapeaRisk TreasuryProfile
Maria LlanoChief OfficerProfile
M TubauCo AffairsProfile
Steven JDEx ChairmanProfile
Montserrat LlamasChief OfficerProfile
Vctor DeuCoCEO DirectorProfile

Additional Tools for Grifols Pink Sheet Analysis

When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.